Health-Related Quality of Life in Gay Men With Localized Prostate Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
David Latini, Baylor College of Medicine
ClinicalTrials.gov Identifier:
NCT00828633
First received: January 23, 2009
Last updated: July 24, 2013
Last verified: July 2013

January 23, 2009
July 24, 2013
August 2008
December 2010   (final data collection date for primary outcome measure)
  • Effect of disease factors and treatment factors on subjective well-being [ Time Frame: Cross-sectional retrospective study, one timepoint ] [ Designated as safety issue: No ]
  • Effect of disease factors and treatment factors on illness intrusiveness [ Time Frame: Cross-sectional retrospective study, one timepoint ] [ Designated as safety issue: No ]
  • Effect of psychosocial factors on subjective well-being [ Time Frame: Cross-sectional retrospective study, one timepoint ] [ Designated as safety issue: No ]
  • Effect of disease factors and treatment factors on subjective well-being [ Designated as safety issue: No ]
  • Effect of disease factors and treatment factors on illness intrusiveness [ Designated as safety issue: No ]
  • Effect of psychosocial factors on subjective well-being [ Designated as safety issue: No ]
Complete list of historical versions of study NCT00828633 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Health-Related Quality of Life in Gay Men With Localized Prostate Cancer
PATIENT-REPORTED OUTCOMES FOR GAY MEN WITH LOCALIZED PROSTATE CANCER

RATIONALE: Gathering information about prostate cancer, treatment, and quality of life from gay men with prostate cancer may help doctors plan the best treatment.

PURPOSE: This clinical trial is collecting information about health-related quality of life from gay men with localized prostate cancer.

OBJECTIVES:

  • To enroll 200 gay men with localized prostate cancer in a cross-sectional study of prostate cancer outcomes.
  • To complete an R01 application using pilot data collected from these patients.
  • To complete manuscripts describing the factors that influence quality of life and treatment satisfaction in these patients.

OUTLINE: Patients complete a web-based survey about their disease (biopsy Gleason score, PSA at diagnosis, and T-stage), treatment (treatment type, time since treatment, and use of healthcare services [e.g., oral medications for erectile dysfunction]), symptom distress, and psychosocial factors (ethnicity, health literacy, level of social support, communication with provider, relationship status, and communication with partner) that affect their health-related quality of life. The data will be used to provide the information necessary to tailor an existing prostate cancer survivorship intervention to address the specific needs of gay men with prostate cancer.

Observational
Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional
Not Provided
Not Provided
Non-Probability Sample

Convenience sample contacted via Internet

Prostate Cancer
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
200
December 2015
December 2010   (final data collection date for primary outcome measure)

DISEASE CHARACTERISTICS:

  • Diagnosis of localized prostate cancer

    • No advanced disease
  • Self-identified as gay

PATIENT CHARACTERISTICS:

  • Able to complete an online questionnaire
  • Able to speak and understand English

PRIOR CONCURRENT THERAPY:

  • Not specified
Male
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States,   Canada
 
NCT00828633
CDR0000600597, BCM-H-21892
No
David Latini, Baylor College of Medicine
Baylor College of Medicine
Not Provided
Principal Investigator: David M. Latini, PhD Baylor College of Medicine
Baylor College of Medicine
July 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP